Multivitamin-mineral supplements in the nutrition of patients with obesity and associated diseases
https://doi.org/10.33667/2078-5631-2026-9-23-28
Abstract
Many biologically active substances, including vitamins, essential macro- and microelements, and vitamin-like compounds, have properties that may potentially reduce pathological changes and improve the condition of patients with obesity and associated diseases, such as type 2 diabetes (DМ2), cardiovascular diseases (CVD), and others.
The purpose of this review is to characterize the micronutrient status of patients with obesity, to justify the need for the use of multivitamin-mineral supplements (MMS) in the dietary treatment of this disease, and to determine their doses to ensure clinical effectiveness. Patients with obesity are characterized by multiple micronutrient deficiencies of varying degrees, i.e., a simultaneous lack of several vitamins and minerals. Patients with obesity and/or DМ2 have an increased need for vitamins C and D. Many medications impair the absorption of vitamins. A sufficiently long-term intake of multimicronutrient supplements containing vitamins in a dose commensurate with the recommended daily intake (RDА) leads to an increase blood plasma micronutrient concentration and the elimination of many metabolic disturbances caused by micronutrient deficiencies. The intake of micronutrients in physiological doses should be continuous, because their «leaching» begins after discontinuation, leading to a return to the initial micronutrient deficiency status provided by the basic diet. The selection of multivitamin-mineral supplements for patients with obesity is based on the use of micronutrient doses commensurate with the RDА.
About the Authors
V. M. KodentsovaRussian Federation
Kodentsova Vera M., Dr Bio Sci (habil.), professor, chief researcher at the Laboratory of Vitamins and Minerals
Moscow
A. V. Pogozheva
Russian Federation
Pogozheva Alla V., Dr Med Sci (habil.), professor, leading researcher at the Laboratory of Demography and Nutrition Epidemiology
Moscow
References
1. World Health Organization. Obesity and overweight. Available from: https://www.who.int/newsroom/fact-sheets/detail/obesity-and-overweight.
2. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults. Lancet. 2024; 403 (10431): 1027–1050. DOI: 10.1016/S0140-6736(23)02750-2
3. Morandi A, Umano GR, Vania A, Gugliemi V, Muscogiuri G, Maffeis C, et al. Optimising healthcare transition of adolescents and young adults to adult care: a perspective statement of the Italian Society of Obesity. Eat Weight Disord. 2024; 29 (1): 51.
4. Nutrition Epidemiology: Russia 2018–2023 / edited by V.A. Tutelyan and D.B. Nikityuk.– Moscow: TD DeLi, 2024. 270 p. ISBN978-5-6051148-4-0. (In Russ.).
5. Busetto L, Dicker D, Frühbeck G, Halford JCG, Sbraccia P, Yumuk V, Goossens GH. A new framework for the diagnosis, staging and management of obesity in adults. Nat Med. 2024; 30 (9): 2395–2399. DOI: 10.1038/s41591-024-03095-3
6. Alzaid F., Fagherazzi G., Riveline JP., Bahman F., Al-Rashed F., Al-Mulla F AhmadR Immune cell-adipose tissue crosstalk in metabolic diseases with a focus on type 1 diabetes. Diabetologia. 2025; 68: 1616–1631. https://doi.org/10.1007/s00125-025-06437-z
7. Weijie Z, Meng Z, Chunxiao W, Lingjie M, Anguo Z, Yan Z, Xinran C, Yanjiao X, Li S. Obesity-induced chronic low-grade inflammation in adipose tissue: A pathway to Alzheimer’s disease. Ageing Res Rev. 2024; 99: 102402. DOI: 10.1016/j.arr.2024.102402
8. Kawai T, Autieri MV, Scalia R. Adipose tissue inflammation and metabolic dysfunction in obesity. Am J Physiol Cell Physiol. 2021; 320 (3): C 375–C 391. DOI: 10.1152/ajpcell.00379.2020
9. Marshinskaia O. V., Kazakova T. V., Notova S. V., Molchanov M. K. Changes in the content of macro-and trace elements in type 2 diabetes mellitus. Microelements in medicine. 2021; (S1): 42–43. (In Russ.). DOI: 10.19112/2413-6174-2021-S1-20
10. Beketova N.A, Kosheleva O. V., Vrzhesinskaya O. A., Kodentsova V. M., Sharafetdinov Kh. Kh., Plotnikova O. A., Pilipenko V. V., Alekseeva R. I., Leonenko S. N., Sokolnikov A.A. Supply of vitamins for patients with type 2 diabetes and obesity in the autumn. Cardiovascular Therapy and Prevention. 2019; 18 (1): 95–101. (In Russ.). https://doi.org/10.15829/1728-8800-2019-1-95-101
11. Lapik I.A., Gapparova K.M., Sharafetdinov Kh. Kh., Sorokina E. Yu, Sentsova T.B., Sokolnikov A.A. Study of Micronutrient Status of Patients with Obesity and Diabetes Mellitus Type 2. Difficult patient. 2016; 14 (10–11): 20–22. (In Russ.).
12. Pigarova E.A., Dzeranova L.K. Obesity, diabetes and vitamin D. Obesity and metabolism. 2024; 21 (3): 316–324. (In Russ.). https://doi.org/10.14341/omet13161
13. Kodentsova V.M., Risnik D.V. Micronutrient metabolic networks and multiple micronutrient deficiency: a rationale for the advantages of vitamin-mineral supplements. Microelements in medicine. 2020; 21 (4): 3–20. (In Russ.). DOI: 10.19112/2413-6174-2020-21-4-3-20
14. Orlova S.V., Nikitina E.A., Vodolazkaya A.N., Batysheva T.T., Alekseeva M.V., Balashova N.V., Pigareva Yu.A., Prokopenko E.V. Vitamin D: What do we know by 2024? A review of the evidence on the effects of vitamin D supplementation on the human body. Medical alphabet. 2024; (24): 29–42. (In Russ.). https://doi.org/10.33667/2078-5631-2024-24-29-42
15. Zhou L, Zhang J, Zhang D, Yu Y, Jiang M, Liu H, Li J, Li M, Zhang Z, Guo L. Co-exposure to multiple vitamins and the risk of all-cause mortality in patients with diabetes. Front Endocrinol (Lausanne). 2023; 14: 1254133. DOI: 10.3389/fendo.2023.1254133
16. Vrzhesinskaya O.A., Beketova N.A., Kosheleva O.V., Kodentsova V.M., Sharafetdinov Kh. Kh. Evaluation of vitamin status ofpatients with morbid obesity by the complex of optimal sufficiency criteria. Medical News of North Caucasus. 2020; 15 (4): 504–509. (In Russ.). DOI: https://doi.org/10.14300/mnnc.2020.15118
17. Kodentsova V.M., Vrzhesinskaya O.A., Kosheleva O.V., Beketova N.А., Sharafetdinov Kh. Kh. Antioxidant vitamin status of obese patients in terms of the risk of comorbidities. Obesity and metabolism. 2020;17(1):22–32. (In Russ.). DOI: https://doi.org/10.14341/omet10144
18. Kodentsova V. M., Risnik D. V., Sharafetdinov Kh. Kh. Vitamin-mineral supplements and biologically active substances in the diet of patients with type 2 diabetes mellitus. Trace elements in medicine. 2023; 24 (2): 12–24. (In Russ.). DOI: 10.19112/2413-6174-2023-24-2-12-24
19. Polkovnikova M.S. Assessment of micronutrient status in patients with arterial hypertension living in the Tyumen region. Vopr. dietol. (Nutrition). 2024; 14 (4): 53–58. (In Russ.). DOI: 10.20953/2224-5448-2024-4-53-58
20. Suplotova L.A., Avdeeva V.A., Pigarova E.A., Rozhinskaya L. Ya., Troshina E.A. Vitamin D deficiency in Russia: the first results of a registered, noninterventional study of the frequency of vitamin D deficiency and insufficiency in various geographic regions of the country. Problems of Endocrinology. 2021; 67 (2): 84–92. (In Russ). DOI: 10.14341/probl12736
21. Fu Y, Zhu Z, Huang Z, He R, Zhang Y, Li Y, Tan W, Rong S. Association between Vitamin B and Obesity in Middle-Aged and Older Chinese Adults. Nutrients. 2023; 15 (3): 483. DOI: 10.3390/nu15030483
22. Churuangsuk C, Hall J, Reynolds A, Griffin SJ, Combet E, Lean ME. Diets for weight management in adults with type 2 diabetes: an umbrella review of published meta-analyses and systematic review of trials of diets for diabetes remission. Diabetologia. 2022; 65 (1): 14–36. DOI: 10.1007/s00125-021-05577-2
23. Kodentsova V. M., Vrzhesinskaya O. A., Leonenko S. N., Sharafetdinov Kh. Kh., Risnik D. V. Multicomponent specialized dietary product for patients with diabetic nephropathy and obesity: expected and achieved effects. Vopr. Dietol. (Nutrition). 2022; 12 (2): 5–14. (In Russian). DOI: 10.20953/2224-5448-2022-2-5-14
24. Pilipenko V. V., Sharafetdinov Kh. Kh., Plotnikova O. A., Alekseeva R. I., Kondratieva O.V. Monitoring vitamin status in patients with type 2 diabetes mellitus. Voprosy pitaniia [Problems of Nutrition]. 2015; 84 (S5): 65. (In Russ.).
25. Mohn E.S., Kern H.J., Saltzman E., Mitmesser S.H., McKay D.L. Evidence of drug–nutrient interactions with chronic use of commonly prescribed medications: an update. Pharmaceutics. 2018; 10 (1): 36. DOI: 10.3390/pharmaceutics10010036
26. Zhelyazkova-Savova MD, Yotov YT, Nikolova MN, Nazifova-Tasinova NF, Vankova DG, Atanasov AA, Galunska BT. Statins, vascular calcification, and vitamin K-dependent proteins: Is there a relation? Kaohsiung J Med Sci. 2021; 37 (7): 624–631. DOI: 10.1002/kjm2.12373
27. Kancherla V, Garn JV, Zakai NA, Williamson RS, Cashion WT, Odewole O, Judd SE, Oakley Jr GP. Multivitamin use and serum vitamin B12 concentrations in older-adult metformin users in REGARDS, 2003–2007. PLoS One. 2016; 11 (8): e0160802. DOI: 10.1371/journal.pone.0160802
28. Pallotti F, Bergamini C, Lamperti C, Fato R. The roles of coenzyme Q in disease: direct and indirect involvement in cellular functions. Int J Mol Sci. 2022; 23 (1): 128. DOI: 10.3390/ijms23010128
29. Carr AC, Lunt H, Wareham NJ, Myint PK. Estimating Vitamin C Intake Requirements in Diabetes Mellitus: Analysis of NHANES2017–2018 and EPIC-Norfolk Cohorts. Antioxidants (Basel). 2023; 12 (10): 1863. DOI: 10.3390/antiox12101863
30. Carr AC, Myint PK, Vijewardane SC, Johnstone AM, Crook J, Lykkesfeldt J. An increasing proportion of the population is not covered by the current RDA for vitamin C – interrogation of EPIC-Norfolk and NHANES2017/2018 cohorts. Crit Rev Food Sci Nutr. 2024: 1–12. DOI: 10.1080/10408398.2024
31. Bess Dawson-Hughes, Elsa M Konieczynski, Lisa Ceglia, Obesity may extend the time required to reach a steady-state 25-hydroxyvitamin D level after initiating vitamin D supplementation. JBMR Plus. 2025; ziaf030. https://doi.org/10.1093/jbmrpl/ziaf030
32. Kodentsova V.M., Risnik D.V. Micronutrient metabolic networks and multiple micronutrient deficiency: a rationale for the advantages of vitamin-mineral supplements. Trace elemets in medicine. 2020; 21 (4): 3–20. (In Russ.). DOI: 10.19112/2413-6174-2020-21-4-3-20
33. Kodentsova V.M., Risnik D.V., Nikitiuk D.B., Tutelyan V.A. Multivitamin-mineral supplementation in medical nutrition. Consilium Medicum. 2017; 19 (12): 76–83. (In Russ.). DOI: 10/26442/2075-1753_19/12/76-83
34. Jenkins D.J., Spence J.D., Giovannucci E.L., Kim Y.I., Josse R.G., Vieth R., Sahye-Pudaruth S., Paquette M., Patel D., Mejia S.B., Viguiliouk E., Nishi S.K., Kavanagh M., Tsirakis T., Kendallj W.C., Pichika S.C., Sievenpiper J.L. Supplemental vitamins and minerals for cardiovascular disease prevention and treatment: JACC focus seminar. Journal of the American College of Cardiology. 2021; 77 (4): 423–436. https://doi.org/10.1016/j.jacc.2020.09.619
35. Li K., Liu C., Kuang X., Deng Q., Zhao F., Li D. Effects of Multivitamin and Multimineral Supplementation on Blood Pressure: A Meta-Analysis of 12 Randomized Controlled Trials. Nutrients. 2018; 10: 1018. DOI: 10.3390/nu10081018
36. Wang C, Li Y, Zhu K, Dong YM, Sun CH. Effects of supplementation with multivitamin and mineral on blood pressure and C-reactive protein in obese Chinese women with increased cardiovascular disease risk. Asia Pac J Clin Nutr. 2009; 18 (1): 121–30.
37. Anders S, Schroeter C. The impact of nutritional supplement intake on diet behavior and obesity outcomes. PLoS One. 2017 Oct 9; 12 (10): e0185258. DOI: 10.1371/journal.pone.0185258
38. Lapik I.A., Sokolnikov A.A., Sharafetdinov Kh. Kh., Sentsova T.B., Plotnikova O.A. Assessment of efficiency of dietotherapy with addition of a vitamin-mineral complex in patients with diabetes mellitus type 2. Voprosy pitaniia [Problems of Nutrition]. 2014; 83 (3): 74–81. (In Russ.).
39. Petunina N.A., Shikh E.V., Galstyan K.O., Khasanova E.R., Ramenskaya G.V. Possibilities of using the Alfavit vitamin-mineral complex. Diabetes in the complex therapy of diabetic polyneuropathy in patients with type 2 diabetes mellitus. Effective pharmacotherapy. 2012; (51): 44–51. (In Russ.).
40. Wallace T.C., Frankenfeld C.L., Frei B., Shah A.V., Yu C.R., van Klinken B.J.W., Adeleke M. Multivitamin/multimineral supplement use is associated with increased micronutrient intakes and biomarkers and decreased prevalence of inadequacies and deficiencies in middle-aged and older adults in the United States. Journal of nutrition in gerontology and geriatrics. 2019; 38 (4): 307–328. https://doi.org/10.1080/21551197.2019.1656135
41. Kodentsova V.M., Risnik D.V., Sharafetdinov Kh. Kh. Vitamin-mineral supplements and biologically active substances in the diet of patients with type 2 diabetes mellitus. Trace elements in medicine. 2023; 24 (2): 12–24. (In Russ.). DOI: 10.19112/2413-6174-2023-24-2-12-24
42. Ladodo O.B., Risnik D.V., Pavlovich S.V., Kodentsova V.M. [Principles of replenishing micronutrient deficiency. Meditsinskiy opponent = Medical Opponent. 2024; 3 (27): 32–37. (In Russ).
43. Kodentsova V.M., Risnik D.V., Moiseenok A.G. Algorithm for effective application of vitamin-mineral complexes. Journal of the Grodno State Medical University. 2024; 22 (2): 177–184. (In Russ.). https://doi.org/10.25298/2221-8785-2024-22-2-177-184
44. Evert A. B., Dennison M., Gardner C. D., Garvey W. T., Lau K. H.K., MacLeod J., Raquel J.M., Rawlings P.K., Robinson S., Saslow L., Uelmen S., Urbanski P.B,. Yancy Jr. W.S., Yancy Jr W.S. Nutrition therapy for adults with diabetes or prediabetes: a consensus report. Diabetes Care. 2019; 42 (5): 731–754. https://doi.org/10.2337/dci19-0014
Review
For citations:
Kodentsova V.M., Pogozheva A.V. Multivitamin-mineral supplements in the nutrition of patients with obesity and associated diseases. Medical alphabet. 2026;(9):23-28. (In Russ.) https://doi.org/10.33667/2078-5631-2026-9-23-28
JATS XML
























